It was announced that the U.S. Drug Enforcement Administration (DEA), the federal agency responsible for enforcement of federal drug laws, will take up the recommendation from the U.S. Health and Human Services (HHS), and reschedule marijuana (cannabis) from the current Schedule I to Schedule III under the Controlled Substances Act (CSA). Rescheduling will have major …
Category: Cannabis IP
U.S. Patent No. PP31,874 P3
U.S. Patent No. PP31,874 P3 (‘874) issued on June 16, 2020 for “Cannabis Plant Named ‘Holy Crunch.” It was issued to inventor Mark Anthony Lewis and Steven Robert Haba, of Westlake Village, California and applicant/assignee Biotech Institute, LLC of Westlake Village, California. The ‘874 patent is a plant patent under 35 U.S.C. §161, which protects …
U.S. Patent No. PP31,707 P3
U.S. Patent No. PP31,707 P3 (‘707) issued onapril 28, 2020, for “Cannabis Plant Named ‘Grape Lollipop’.” It was issued to inventor Mark Anthony Lewis and Steven Robert Haba, of Westlake Village, California and applicant/assignee Biotech Institute, LLC of Westlake Village, California. The ‘707 patent is a plant patent under 35 U.S.C. §161, which protects new …
U.S. Patent No. 10,625,177 B2
U.S. Patent No. 10,625,177 B2 (‘177) issued on April 21, 2020, for “Bioavailable Cannabis Plant Blend.” It was issued to inventor David Harold Moore of Henderson, Nevada. The inventor discusses in the background of the specification how he has Asperger’s Syndrome, a mild form of autism. This autism can lead to an autoimmune disorder causing …
New Trademark Application Reveals Problems with Mad Rush for “Hot” Trends
A new trademark application for COVID-KUSH was filed with the U.S. Patent and Trademark Office (USPTO), on July 30, 2020. The applicant is Anthony Ariza dba Covid-Kush of Santa Clara, California. The identification of goods and services indicates it is a mark for use in International Class 30, for gelatin-based chewy candies; flavored, sweetened gelatin …
U.S. Patent No. 10,512,629 B1
U.S. Patent No. 10,512,629 B1 (‘629) issued on December 24, 2019, entitled ”Compositions Comprising a Cannabinoid and Spilanthol.” It was issued to inventor Zohar Koren of Gan Ner, Israel. The applicant/assignee is SciCann Therapeutics, Inc., of Toronto, Canada. The specification discloses fixed-dose combination (FDC) therapeutic compound of one cannabinoid and spilanthol for treatment of various …
U.S. Patent No. 10,485,373 B1
U.S. Patent No. 10,485,373 B1 (‘373) issued on November 26, 2019, entitled ”Method for Cannabinoid Delivery Into Beverages.” It was issued to inventors Rory Chesley Patrick Millikin of Kelowna, Canada, and Matthew Kennedy of Westminster, California. The assignee is Drive Foods Corporation of Westminster, California. The specification discloses a new cannabinoid beverage delivery system. According …
U.S. Patent No. 10,485,771 B2
U.S. Patent No. 10,485,771 B2 (‘771) issued on November 26, 2019, entitled ”Methods of Regulating Cannabinoid Receptor Activity-Related Disorders and Diseases.” It was issued to inventors Irving W. Wainer of Washington, DC, Michel Bernier of Pikesville, Maryland, and Rajib K. Paul of Baltimore, Maryland. The applicant/assignee is the U.S. Department of Health & Human Services, …
U.S. Patent No. 10,456,435 B2
U.S. Patent No. 10,456,435 B2 (‘435) issued on October 29, 2019, entitled ”Topical Antiviral Formulations and Methods of Using the Same.” It was issued to applicant/inventor Christopher A. McElvany of Denver, Colorado. The specification discloses an antiviral composition for treatment of herpes simplex virus (HSV), or the common cold sore. The sole claim in the …
U.S. Patent No. 10,383,358 B2
U.S. Patent No. 10,383,358 B2 (‘358) issued on August 20, 2019, entitled ”Cannabinoid Containing Cannabis Extract Infused into Rolling Paper.” It was issued to inventors Benjamin S. Kaplan of Scarsdale, New York, Tobias Paquet, of Davis California, and Jason Paul Negrette, of Pacifica, California. The applicant/assignee is Digital Rarity, LLC, of New York, New York. …